Cancer Care Ontario | Cancer Care Ontario

9 Results

Guidelines and Advice

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Status: Archived
ID: 2-23
Version: 2-23 Version 2

Oct 2015

Guidelines and Advice

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary

Status: Current
ID: 15-14

Nov 2015

Statistical Reports

Cancer in the Métis People of Ontario: Risk Factors and Screening Behaviours

Jul 2015

Statistical Reports

Cancer Risk Factors in Ontario: Healthy Weights, Healthy Eating and Active Living

Mar 2015

Cancer facts

Cancers Related to Excess Body Weight on the Rise in Ontario

Dec 2015

Guidelines and Advice

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Status: Current
ID: GL-C50-17

Jan 2015

Guidelines and Advice

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Status: Current
ID: GL-C50-18

Jan 2015

Regimen

CHOP+R-DHAP+R

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

ODB - General Benefit

dexamethasone

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Sep 2020

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020